Redhawk Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Redhawk Wealth Advisors's BMY Position: Q3 2026 in Review
Redhawk Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q3 2026, buying an estimated $14.9K and bringing the position to 17,444 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #156.
Redhawk Wealth Advisors first reported a position in BMY in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.33M in Q1 2023. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Redhawk Wealth Advisors held 17,444 shares of Bristol-Myers Squibb worth $1.09M as of Q3 2026.
- Redhawk Wealth Advisors bought 235 Bristol-Myers Squibb shares in Q3 2026, an estimated $14.9K.
- Bristol-Myers Squibb made up 0.11% of Redhawk Wealth Advisors's portfolio in Q3 2026, its #156 holding.
- Redhawk Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 17 quarters since.
- Redhawk Wealth Advisors's Bristol-Myers Squibb position peaked at $1.33M in Q1 2023.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Redhawk Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.